Zhenghuan Fang

发表

Systemic and local metabolic alterations in sleep deprivation-induced stress: A multi-platform mass- spectrometry-based lipidomics and metabolomics approach.

Nguyen Phuoc Long, Sun Jo Kim, S. Kwon, 2019, Journal of proteome research.

Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/MAPK Pathway of Hepatic Stellate Cells

J. E. Lee, Soon-Sun Hong, J. Ryu, 2020, Biomolecules & therapeutics.

HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer

Soon-Sun Hong, Sungwoo Hong, M. Rumman, 2016, Oncotarget.

ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5a

N. Tan, B. Han, J. E. Lee, 2020, EMBO molecular medicine.

CD-200 induces apoptosis and inhibits Bcr-Abl signaling in imatinib-resistant chronic myeloid leukemia with T315I mutation.

Hyunseung Lee, Soon-Sun Hong, M. Rumman, 2015, International journal of oncology.

Combination Therapy of the Active KRAS-Targeting Antibody inRas37 and a PI3K Inhibitor in Pancreatic Cancer

S. Shin, J. E. Lee, Yong-Sung Kim, 2021, Biomolecules & therapeutics.

Optimization and biological evaluation of aminopyrimidine-based IκB kinase β inhibitors with potent anti-inflammatory effects.

Soon-Sun Hong, Sungwoo Hong, Sungwoo Jung, 2016, European journal of medicinal chemistry.

HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation

Soyoung Lee, Jinhe Kim, Hyunseung Lee, 2014, Oncotarget.

HS-438, a new inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia.

Jinhe Kim, Hyunseung Lee, Soon-Sun Hong, 2014, Cancer letters.

Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape.

S. Shin, J. E. Lee, Yong-Sung Kim, 2021, Cancer letters.

HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.

You-Sun Kim, J. E. Lee, Soon-Sun Hong, 2019, Cancer letters.

PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis

Hyun-Ju Park, Soon-Sun Hong, K. Jung, 2019, Biomolecules & therapeutics.

Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.

Soon-Sun Hong, K. Jung, Zhenghuan Fang, 2017, Cancer letters.

KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer.

S. Shin, Yong-Sung Kim, Soon-Sun Hong, 2018, Cancer letters.

Crizotinib Exhibits Antitumor Activity by Targeting ALK Signaling not c-MET in Pancreatic Cancer

Mi-hyun Kim, Soon-Sun Hong, K. Jung, 2014, Oncotarget.

HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer.

Hyunseung Lee, Soon-Sun Hong, Sungwoo Hong, 2014, International journal of oncology.

A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer.

A. Pae, C. G. Gadhe, Soon-Sun Hong, 2018, Cancer letters.

Long noncoding RNA SNHG10 promotes colorectal cancer cells malignant progression by targeting miR-3690

Zhenghuan Fang, Hao Zhang, Yesong Guo, 2021, Bioengineered.

MEK blockade overcomes the limited activity of palbociclib in head and neck cancer

Soon-Sun Hong, K. Jung, Zhenghuan Fang, 2020, Translational oncology.

Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer

Soon-Sun Hong, K. Jung, Zhenghuan Fang, 2017, Oncotarget.

Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties

H. Maeng, Soon-Sun Hong, Sungwoo Hong, 2018, Molecules.

ANGPTL4 accelerates KRASG12D-Induced acinar to ductal metaplasia and pancreatic carcinogenesis.

J. Kim, Soon-Sun Hong, K. Jung, 2021, Cancer letters.

Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway

Soon-Sun Hong, M. Rumman, K. Jung, 2018, Cellular Physiology and Biochemistry.